Godavari Drugs Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 26.10 | 32.97 | 38.75 |
| Operating Expense | 23.18 | 28.98 | 34.20 |
| Net Profit | 1.09 | 1.63 | 2.66 |
| Net Profit Margin | 4.18 | 4.94 | 6.86 |
| Earning Per Share | 1.45 | 2.17 | 3.53 |
| EBIDTA | 2.91 | 4 | 4.55 |
| Effective Tax Rate | 5.50 | 9.50 | 2.86 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 26.10 |
| Operating Expense | 23.18 |
| Net Profit | 1.09 |
| Net Profit Margin | 4.18 |
| Earning Per Share | 1.45 |
| EBIDTA | 2.91 |
| Effective Tax Rate | 5.50 |
Invest in Godavari Drugs Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 156.71 | 159.62 | 161.11 |
| Operating Expenses Annual | 143.41 | 149.70 | 149.82 |
| Operating Profit Annual | 13.83 | 10.81 | 11.57 |
| Interest Annual | 4.92 | 3.93 | 2.85 |
| Depreciation | 1.99 | 1.94 | 1.70 |
| Net Profit Annual | 5.55 | 3.79 | 5.25 |
| Tax Annual | 1.37 | 1.15 | 1.78 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 156.71 |
| Operating Expenses Annual | 143.41 |
| Operating Profit Annual | 13.83 |
| Interest Annual | 4.92 |
| Depreciation | 1.99 |
| Net Profit Annual | 5.55 |
| Tax Annual | 1.37 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 3.08 | 2.28 | 1.64 |
| Cash Flow from Operations | 18.41 | 13.22 | 11.23 |
| Cash Flow from Investing | -13.22 | -8.64 | -4.97 |
| Cash Flow from Financing | -5.65 | -3.77 | -5.62 |
| Cash Flow at the End | 2.62 | 3.08 | 2.28 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 3.08 |
| Cash Flow from Operations | 18.41 |
| Cash Flow from Investing | -13.22 |
| Cash Flow from Financing | -5.65 |
| Cash Flow at the End | 2.62 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 8.83 | 6.77 | 7.18 |
| PBIT Margin (%) | 7.56 | 5.56 | 6.13 |
| PBT Margin (%) | 6.02 | 4.14 | 3.98 |
| Net PROFIT Margin (%) | 3.54 | 2.37 | 3.26 |
| Return On Networth / Equity (%) | 15.33 | 12.02 | 19.44 |
| Return On Networth /Employed (%) | 12.53 | 12.24 | 18.12 |
| Return On Assets (%) | 5.88 | 5.22 | 9.61 |
| Total Debt / Equity (X) | 1.59 | 1.28 | 0.99 |
| Asset Turnover Ratio (%) | 1.66 | 2.20 | 2.95 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 8.83 |
| PBIT Margin (%) | 7.56 |
| PBT Margin (%) | 6.02 |
| Net PROFIT Margin (%) | 3.54 |
| Return On Networth / Equity (%) | 15.33 |
| Return On Networth /Employed (%) | 12.53 |
| Return On Assets (%) | 5.88 |
| Total Debt / Equity (X) | 1.59 |
| Asset Turnover Ratio (%) | 1.66 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 26.68 | 24.91 | 26.25 |
| Total Current Assets Annual | 88.48 | 87.01 | 74.33 |
| Non Current Assets Annual | 46.27 | 34.43 | 27.08 |
| Total Shareholders Funds Annual | 38.97 | 33.42 | 29.63 |
| Total Assets Annual | 134.75 | 121.43 | 101.41 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 26.68 |
| Total Current Assets Annual | 88.48 |
| Non Current Assets Annual | 46.27 |
| Total Shareholders Funds Annual | 38.97 |
| Total Assets Annual | 134.75 |
No Data Availabe
